A team of researchers assessed COVID-19 outcomes in patients with neurodegenerative diseases compared with patients without such disease.
Rita Aghjayan is the editor of Hematology Advisor. She holds a BS in biology with minors in physics and chemistry from Pace University in New York. Prior to joining Haymarket, Rita conducted research both in quantum physics and microbial ecology.
All articles by Rita Aghjayan
A team of investigators sought to determine whether κ- and λ-FLC index may predict early multiple sclerosis disease activity independent of demographics, clinical, and MRI characteristics.